Blue Latitude Health’s consultancy is based on a rich vein of expert knowledge. Here you’ll find thought-provoking commentary, articles, and downloadable resources created by our consultants.
Explore our ideas and get a deeper understanding of the current and future trends in healthcare:
|30th March 2016
Healthcare is undergoing a transformative change, which presents challenges to all players in the sector. Established healthcare players like pharma need to control and shape their emerging roles.
In this article, Head of Insight Martine Leroy explores how pharma could learn from translational research organisations in adapting their approach to the changing healthcare landscape.
|15th March 2016
Blue Latitude Health is now working in multiple myeloma (MM), and with each publication that emerges, it’s clear that we are witnessing a transformation in the treatment of multiple myeloma. In this article, Consultant David Cooney will take you through how that transformation has happened, and where the treatment of multiple myeloma is heading.
|10th March 2016
As the wider industry becomes increasingly competitive, clients have started to become more procurement-led, looking for ways to improve margins and efficiencies in their business. The impact on agencies has been substantial, with fewer suppliers on rosters and more aggressive payment terms.
In this article, Co-Founder and Managing Director Martin Brass discusses the evolution of procurement and the new client-agency relationship.
|7th March 2016
Within the pharma and healthcare industry, the introduction of a user-centred approach that incorporates best practice user experience research and design is still rare. Often the world of user experience (UX), its activities, methods, and deliverables are not well understood within this industry.
In this article, Head of Customer Experience Elisa del Galdo breaks down how to understand the return on investment of user experience methodology.
|7th March 2016
Not all organisations are in a position to look at maturity – for some, there’s still a pressing question that needs answering: Why does content need a strategy?
In this article, Content Marketing Manager Liz Inskip and guest blogger Adwoa Baah explain how having a documented strategy for content creation, distribution, management, and governance will empower your brand teams and create organisational efficiencies.
|2nd March 2016
We interviewed Wayne Atherden, Procurement Director Commercial Services at Janssen, our European procurement contact, to get a fuller understanding of his view on the issues facing brand teams and how agencies help to deliver value. Here is what he had to say.
|26th February 2016
In healthcare, customer journey maps can be very complex due to the fact that healthcare systems are often convoluted and extensive. This creates a web of interconnected touchpoints and interdependent stakeholders that is too cluttered and difficult to use.
In 2016, it’s time to update our model for the customer journey. Customer Experience Consultant Anna Tamasi talks us through the future of journey mapping.
|19th February 2016
Pharma still has silos around key functions in the marketing process, which has the unintended consequence of often putting these functions at odds with the brand teams. In 2016, it’s time to bring these teams together and move them toward a common goal – delivering for your customers to enable better patient outcomes. Head of Commercial Matt Bolton breaks down what we mean when we talk about eliminating the last silos in pharma marketing.
|15th February 2016
Healthcare is not a consumer-driven market where we can assume that patient-centred innovations will automatically influence adoption within doctor communities. In this article, Customer Experience Consultant Anna Tamasi highlights the most common usability and user experience implications that the digitalisation of healthcare poses on doctors' professional lives.
|3rd February 2016
About ten years ago, personalised medicine was a major step forward – tailoring treatments based on individual patient history and information. Fast forward to 2015, and investigating the central dogma of biology is still a major focus of healthcare research.
Consultant David Cooney talks us through what this progress in genomics means for pharma in 2016.